TF/FVIIa complex inhibitors, including TFPI, possess opposing functions by reducing tumor development and metastasis (Amirkhosravi et al., 2007; Bajou et al., 2008; Fayard et al., 2009; Lavergne et al., 2013; Wang et al., 2018). The gene discussed is TF; the disease is neoplasm.